BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16088103)

  • 1. Role of the dialyzer membrane on the overall phosphate kinetics during hemodialysis.
    Katopodis KP; Chala A; Koliousi E; Takouli L; Kalaitzidis R; Theodorou J; Siamopoulos KC
    Blood Purif; 2005; 23(5):359-64. PubMed ID: 16088103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inorganic phosphorus homeostasis during the first hour of dialysis.
    Katopodis KP; Dounousi EC; Challa AS; Vlachou IA; Karasavvidou DP
    Ren Fail; 2011; 33(6):562-7. PubMed ID: 21663386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethylene-vinyl alcohol copolymer dialyzer membrane reduces protein oxidation in hemodialysis patients.
    Matsumoto Y; Mukai M; Arihara K; Saito T; Kumagai H
    Ren Fail; 2011; 33(4):382-7. PubMed ID: 21529266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
    Lonnemann G; Koch KM; Shaldon S; Dinarello CA
    J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemodialysis membrane type on parathyroid hormone removal.
    Kudlac H; Fielding AM; Williams AJ
    Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate kinetics during different dialysis modalities.
    Ratanarat R; Brendolan A; Volker G; Bonello M; Salvatori G; Andrikos E; Yavuz A; Crepaldi C; Ronco C
    Blood Purif; 2005; 23(1):83-90. PubMed ID: 15627742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes.
    Ifediora OC; Teehan BP; Sigler MH
    ASAIO J; 1992; 38(3):M697-701. PubMed ID: 1457952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis.
    Abe M; Okada K; Ikeda K; Matsumoto S; Soma M; Matsumoto K
    Artif Organs; 2011 Apr; 35(4):398-403. PubMed ID: 21314833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.
    Lee KB; Kim B; Lee YH; Yoon SJ; Kang WH; Huh W; Kim DJ; Oh HY; Kim YG
    Nephron Clin Pract; 2004; 97(1):c5-10. PubMed ID: 15153761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No generation of bradykinin with a new polyacrylonitrile membrane (SPAN) in haemodialysis patients treated with ACE inhibitors.
    Mannstadt M; Touam M; Fink E; Ureña P; Hruby M; Zingraff J; Uhlenbusch-Körwer I; Grassmann A; Lemke HD; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(9):1696-700. PubMed ID: 8559491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-specific phosphorus mobilization clearance during nocturnal and short daily hemodialysis.
    Agar BU; Troidle L; Finkelstein FO; Kohn OF; Akonur A; Leypoldt JK
    Hemodial Int; 2012 Oct; 16(4):491-6. PubMed ID: 22574966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.
    De Smet R; Dhondt A; Eloot S; Galli F; Waterloos MA; Vanholder R
    Nephrol Dial Transplant; 2007 Jul; 22(7):2006-12. PubMed ID: 17468506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
    Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
    Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.